Big Meeting Could Mean Big Gains For Biotech Investors

While the World Cup Kicks off in South Africa, biotech investors are having their own world class event. The American Society of Clinical Oncology (ASCO) kicked off this June 4th and will run until today. This is the most important meeting for the biotech sector and is attended by doctors and leaders in the biotech industry, but also biotech investors. Many important up and coming biotech and drug companies will release new clinical data and present their findings to community. While individual biotech stocks can seem like lotto tickets to some investors, offering big gains to those who pick the right companies, the sector is volatile. Investors wanting to play the bottle-rocket stocks might be suited in an exchange traded fund that tracks the sector. The iShares Nasdaq Biotechnology

and SPDR S&P Biotech

allow investors to bet on basket of these stocks while allowing for diversification benefits. Look for these to ETFs to outperform in the short term after directly after the conference and into the future as the sector remains a good bet on the future of healthcare.